Drug Companies Must Forgo Mid-Year Price Increases While Millions of Americans Grapple With Historic Economic Uncertainty Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) announced Tuesday the launch of a campaign encouraging Big Pharma companies to suspend traditional mid-year price hikes while millions of Americans grapple with economic uncertainty caused by the COVID-19 […]
Comprehensive Effort Will Target D.C., In Addition To Nine Presidential & Senate Battleground States Calling For Passage of Bipartisan Solutions to Lower Prescription Drug Prices Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) announced Tuesday the start of a comprehensive, seven-figure campaign targeting Washington, D.C., in addition to nine presidential and Senate battleground states, […]
Trump Can Use Platform To Demand Congress Hold Big Pharma Accountable & Deliver Relief For Americans Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) said Monday that President Trump will have a unique opportunity during the 2020 State of the Union address to advance his commitment to lowering prescription drug prices – by […]
Lawmakers Hold Strong, Advance Trade Deal Without Big Pharma-Backed Provision on Biologic Exclusivity Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) applauded U.S. Senators Thursday who voted to approve the revised U.S.-Mexico-Canada Agreement (USMCA) without a provision that would have helped brand name drug companies undermine competition and keep prices high for American […]
Passage of Bipartisan, Market-based CREATES Act Will Be A First Step in the Right Direction But Patients Need Washington to Do Much More Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) commended Congress for including the bipartisan, market-based Creating and Restoring Equal Access To Equivalent Samples (CREATES) Act in a spending deal announced […]
Passage of HR3 Adds to Momentum to Hold Big Pharma Accountable; Now Congress Must Move Swiftly to Get Bipartisan Reforms Passed into Law Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) commended lawmakers in the U.S. House for passing market-based reforms included in the Elijah E. Cummings Lower Drug Costs Now Act (HR3) Thursday […]
Revisions to Historic Trade Deal Remove Big Pharma Carveout Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) commended the White House and lawmakers in the U.S. House for removing provisions from the U.S.-Mexico-Canada Agreement (USMCA) that were supported by Big Pharma and that would have helped brand name drug makers undermine competition and […]
Corporate Filings Show Drug Makers Boosted Payouts for Shareholders 17 Times More Than Increased Investment in ‘Innovation’ Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released an analysis Tuesday that found brand name prescription drug manufacturers used a windfall from the Tax Cuts and Jobs Act of 2017 to line shareholders’ pockets, rather […]
Survey Finds Overwhelming Majorities of Swing State Voters Blame Drug Makers for Rising Prices and Want Congress to Pass Bipartisan Reforms Before Year End Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday on a new survey conducted in five top 2020 Senate battleground states that found an overwhelming majority […]
Washington Can Put Patients First By Amending Trade Provision That Would Hamper Generic and Biosimilar Competition Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) reiterated Wednesday the urgent need for the administration and Congress to amend the proposed U.S.-Mexico-Canada Agreement (USMCA) to remove provisions that would help Big Pharma prevent competition and raise […]